PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; ...

Florida has many friendly small towns, but which ones are ideal for visitors? Here are the Sunshine State's 10 best, ...

The management of rheumatoid arthritis (RA) has significantly improved, but a substantial number of patients still experience ...

John Michael Williams thinks Colorado withholds information on wolves from citizens. In changing that, did he create an ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...

Lee Soo Man spent three decades trying to bring K-pop into the global market, often bending but never breaking his vision ...

Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...

Q3 2025 Earnings Call November 13, 2025 5:00 PM ESTCompany ParticipantsGuilherme Souto - Investor Relations Officer & Director ...

Q3 2025 Earnings Call Transcript November 10, 2025 FibroGen, Inc. beats earnings expectations. Reported EPS is $-1.61, ...

Company to host conference call and webcast today, November 12, at 8:30 am EST/2:30 pm CETIMA402 and IMA401 TCR Bispecifics ...